赛升药业(300485) - 2021 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2021 was CNY 342,775,244.87, an increase of 11.75% compared to the same period last year, and the year-to-date revenue reached CNY 1,212,681,679.32, up 53.26% year-on-year[3] - The net profit attributable to shareholders for Q3 2021 was CNY 52,379,695.74, representing an 18.33% increase year-on-year, while the year-to-date net profit was CNY 137,713,159.02, a 6.63% increase[3] - The basic earnings per share for Q3 2021 was CNY 0.11, up 22.22% year-on-year, and the diluted earnings per share was also CNY 0.11[4] - Total operating revenue for Q3 2021 reached CNY 1,212,681,679.32, a significant increase of 53.1% compared to CNY 791,257,671.76 in the same period last year[28] - Net profit for Q3 2021 was CNY 133,778,745.44, representing a 6.1% increase from CNY 126,247,006.57 in Q3 2020[29] - The company reported a total comprehensive income of CNY 133,581,372.59 for Q3 2021, up from CNY 126,247,006.57 in Q3 2020[31] Assets and Liabilities - The total assets as of September 30, 2021, were CNY 3,690,908,471.22, a 23.40% increase from the end of the previous year[4] - The total assets of the company as of Q3 2021 amounted to CNY 3,690,908,471.22, compared to CNY 2,991,062,511.44 at the end of Q3 2020, reflecting a growth of 23.4%[28] - The total liabilities increased to CNY 730,914,796.40, up from CNY 141,128,369.42, indicating a substantial rise in financial obligations[27] - The company's equity attributable to shareholders reached CNY 2,910,642,193.37, an increase from CNY 2,804,427,300.38 year-over-year[28] Cash Flow - The company's cash flow from operating activities for the year-to-date was CNY 82,079,575.10, down 63.72% compared to the same period last year[3] - The cash inflow from operating activities totaled CNY 1,150,837,917.77, an increase from CNY 891,367,653.51 in the previous period, representing a growth of approximately 29%[34] - The net cash flow from operating activities was CNY 82,079,575.10, down from CNY 226,249,463.81 in the previous period, indicating a decline of about 64%[34] - Cash outflow for purchasing goods and services was CNY 406,687,308.56, significantly higher than CNY 116,697,811.16 in the previous period[34] - The net cash flow from investing activities was negative at CNY -273,881,865.82, an improvement from CNY -530,418,724.81 in the previous period[35] - The company reported a cash outflow of CNY 36,152,698.13 from financing activities, compared to CNY 31,456,497.57 in the previous period, indicating a higher cash outflow[35] Research and Development - Research and development expenses for the year-to-date were CNY 80,473,801.38, an increase of 88.25% year-on-year, indicating a significant investment in R&D[12] - Research and development expenses increased to CNY 80,473,801.38, up 88.5% from CNY 42,749,087.53 in the previous year[29] Receivables and Liabilities - The company reported an increase in trading financial assets by 68.83% year-to-date, reaching CNY 857,121,656.75, due to increased short-term bank investment[8] - The company's accounts receivable increased by 53.10% year-to-date, amounting to CNY 176,394,679.01, primarily due to receivables from a consolidated subsidiary[8] - The company experienced a significant increase in contract liabilities, which rose by 3778.67% year-to-date to CNY 419,956,003.18, mainly from a consolidated subsidiary[10] Investment Income - The investment income for the year-to-date was CNY 28,692,824.28, a 162.72% increase year-on-year, driven by gains from stock sales and investment returns[13] - Cash received from investment income was 31,645,831.76 CNY, an increase of 19,405,691.44 CNY or 158.54% year-over-year, mainly from the sale of part of the company's holdings in Kang Le Wei Shi stocks and increased financial income[16] - Cash paid for investments was 81,000,000.00 CNY, an increase of 28,848,240.00 CNY or 55.32% year-over-year, indicating increased external investments[17] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 34,327, with the largest shareholder holding 49.51% of the shares[20] Other Financial Information - The company received CNY 28,790,292.71 in tax refunds during the period[34] - The company did not adjust the beginning balance sheet items for the new leasing standards as there were no related leasing activities[36] - The third quarter report was not audited[36]